PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Vilja Pietiäinen

University of Helsinki

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · JOURNAL ARTICLE

Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy

Frontiers in Immunology

Early-stage in vitro study using patient-derived cell models without clinical outcomes, animal efficacy data, or in vivo validation; demonstrates proof-of-concept for a combination strategy but requires substantial further development before clinical relevance can be assessed.

PreliminaryIsabel Mogollón Tamara J. Luck Renal and Related Cancers

Study details

DesignIn vitro mechanistic study

InterventionCombination treatment integrating targeted…

ComparatorMonotherapy (either targeted systemic drug…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support